Article
The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society - 1 Feb 2003
Guo Ning, Ye Jing-Jing, Liang Shu-Jian, Mineo Rossana, Li Shu-Lian, Giannini Stefano, Plymate Stephan R, Sikes Robert A, Fujita-Yamaguchi Yoko
Abstract excerpt
Towards understanding the IGF system during cancer growth and progression, progressive prostate cancer models, such as SV40 large T antigen immortalized human prostate epithelial cells (P69, M2182, M2205, and M12) and LNCaP sublines (C4, C4-2, and C4-2B4), were used. IGF-II mRNA levels progressively increase as prostate cancer cells become more tumorigenic and metastatic, suggesting that IGF-II contributes in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
